Summit Therapeutics (SMMT) Return on Assets (2020 - 2025)

Summit Therapeutics has reported Return on Assets for 6 years, with the latest figure at 0.0% in Q3 2025.

• For the quarter ending Q3 2025, Return on Assets changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Sep 2025 stood at 0.0% (changed 0.0% YoY), and the FY2024 full-year result was 0.01%, up 1.0% from the prior year.
• Return on Assets for Q3 2025 stood at 0.0%, up from 0.0% in the prior quarter.
• The five-year high for Return on Assets was 0.0% in Q4 2022, with the low at 0.03% in Q4 2023.
• Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2024.
• Annual changes were most pronounced in 2023 — Return on Assets fell 3 bps — and 2024, when it gained 2 bps.
• Summit Therapeutics' Return on Assets stood at 0.01% in 2021, then jumped by 76 bps to 0.0% in 2022, then sank by 1545 bps to 0.03% in 2023, then soared by 83 bps to 0.01% in 2024, then soared by 55 bps to 0.0% in 2025.
• The last three Return on Assets figures came in at 0.0% (Q3 2025), 0.0% (Q2 2025), and 0.0% (Q1 2025), per Business Quant data.